Antipsychotic efficacy and good tolerability in a Phase III placebo-controlled study of pimavanserin in patients with Parkinson's disease psychosis (ACP-103-020)
Ballard, Clive, Mills, Roger, Williams, Hilde, Chi-Burris, Kathy, Bahr, Daun, Cummings, JeffreyVolume:
9
Langue:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2013.04.361
Date:
July, 2013
Fichier:
PDF, 54 KB
english, 2013
File converter
Plus de résultats de recherche
More benefits 
